|
1
|
Bogousslavsky J, Van Melle G and Regli F:
The lausanne stroke registry: Analysis of 1,000 consecutive
patients with first stroke. Stroke. 19:1083–1092. 1988.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Paciaroni M, Silvestrelli G, Caso V, Corea
F, Venti M, Milia P, Tambasco N, Parnetti L and Gallai V:
Neurovascular territory involved in different etiological subtypes
of ischemic stroke in the perugia stroke registry. Eur J Neurol.
10:361–365. 2003.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Taussky P, Hanel RA and Meyer FB: Clinical
considerations in the management of asymptomatic carotid artery
stenosis. Neurosurg Focus. 31(E7)2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Davies MG and Hagen PO: Pathobiology of
intimal hyperplasia. Br J Surg. 81:1254–1269. 1994.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Subbotin VM: Analysis of arterial intimal
hyperplasia: Review and hypothesis. Theor Biol Med Model.
4(41)2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
O'Brien M and Chandra A: Carotid
revascularization: Risks and benefits. Vasc Health Risk Manag.
10:403–416. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bae C, Szuchmacher M and Chang JB:
Comparative review of the treatment methodologies of carotid
stenosis. Int J Angiol. 24:215–222. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
ACST-2 Collaborative Group. Halliday A,
Bulbulia R, Gray W, Naughten A, den Hartog A, Delmestri A, Wallis
C, le Conte S and Macdonald S. Status update and interim results
from the asymptomatic carotid surgery trial-2 (ACST-2). Eur J Vasc
Endovasc Surg. 46:510–518. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Abbott AL: Medical (nonsurgical)
intervention alone is now best for prevention of stroke associated
with asymptomatic severe carotid stenosis: Results of a systematic
review and analysis. Stroke. 40:e573–e583. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wei X, Sun Y, Han T, Zhu J, Xie Y, Wang S,
Wu Y, Fan Y, Sun X, Zhou J, et al: Upregulation of miR-330-5p is
associated with carotid plaque's stability by targeting Talin-1 in
symptomatic carotid stenosis patients. BMC Cardiovasc Disord.
19(149)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hu W, Chang G, Zhang M, Li Y, Yin L, Huang
Y, Feng C, Gu Y, Wen D and Wang S: MicroRNA-125a-3p affects smooth
muscle cell function in vascular stenosis. J Mol Cell Cardiol.
136:85–94. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bi R, Ding F, He Y, Jiang L, Jiang Z, Mei
J and Liu H: miR-503 inhibits platelet-derived growth
factor-induced human aortic vascular smooth muscle cell
proliferation and migration through targeting the insulin receptor.
Biomed Pharmacother. 84:1711–1716. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cremer S, Michalik KM, Fischer A,
Pfisterer L, Jaé N, Winter C, Boon RA, Muhly-Reinholz M, John D,
Uchida S, et al: Hematopoietic deficiency of the long noncoding RNA
MALAT1 promotes atherosclerosis and plaque inflammation.
Circulation. 139:1320–1334. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gu W, Hong X, Le Bras A, Nowak WN, Issa
Bhaloo S, Deng J, Xie Y, Hu Y, Ruan XZ and Xu Q: Smooth muscle
cells differentiated from mesenchymal stem cells are regulated by
microRNAs and suitable for vascular tissue grafts. J Biol Chem.
293:8089–8102. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lal BK, Dux MC, Sikdar S, Goldstein C,
Khan AA, Yokemick J and Zhao L: Asymptomatic carotid stenosis is
associated with cognitive impairment. J Vasc Surg. 66:1083–1092.
2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rao X, Huang X, Zhou Z and Lin X: An
improvement of the 2^(-delta delta CT) method for
quantitative real-time polymerase chain reaction data analysis.
Biostat Bioinforma Biomath. 3:71–85. 2013.PubMed/NCBI
|
|
17
|
Beckman JA: Management of asymptomatic
internal carotid artery stenosis. JAMA. 310:1612–1618.
2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Goldstein LB: Screening for asymptomatic
carotid artery stenosis: Evidence-based opinion. JAMA Intern Med.
176:633–634. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Dharmakidari S, Bhattacharya P and
Chaturvedi S: Carotid artery stenosis: Medical therapy, surgery,
and stenting. Curr Neurol Neurosci Rep. 17(77)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Nederkoorn PJ, van der Graaf Y and Hunink
MG: Duplex ultrasound and magnetic resonance angiography compared
with digital subtraction angiography in carotid artery stenosis: A
systematic review. Stroke. 34:1324–1332. 2003.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jahromi AS, Cina CS, Liu Y and Clase CM:
Sensitivity and specificity of color duplex ultrasound measurement
in the estimation of internal carotid artery stenosis: A systematic
review and meta-analysis. J Vasc Surg. 41:962–972. 2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shi HB, Yu JX, Yu JX, Feng Z, Zhang C, Li
GY, Zhao RN and Yang XB: Diagnostic significance of microRNAs as
novel biomarkers for bladder cancer: A meta-analysis of ten
articles. World J Surg Oncol. 15(147)2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sun H, Wang L, Zhao Q and Dai J:
Diagnostic and prognostic value of serum miRNA-1290 in human
esophageal squamous cell carcinoma. Cancer Biomark. 25:381–387.
2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li Z, Ma YY, Wang J, Zeng XF, Li R, Kang W
and Hao XK: Exosomal microRNA-141 is upregulated in the serum of
prostate cancer patients. Onco Targets Ther. 9:139–148.
2015.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Chan CM, Lai KKY, Ng EKO, Kiang MN, Kwok
TWH, Wang HK, Chan KW, Law TT, Tong DK, Chan KT, et al: Serum
microRNA-193b as a promising biomarker for prediction of
chemoradiation sensitivity in esophageal squamous cell carcinoma
patients. Oncol Lett. 15:3273–3280. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Luque A, Farwati A, Krupinski J and Aran
JM: Association between low levels of serum miR-638 and
atherosclerotic plaque vulnerability in patients with high-grade
carotid stenosis. J Neurosurg. 131:72–79. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Fei Y, Hou J, Xuan W, Zhang C and Meng X:
The relationship of plasma miR-503 and coronary collateral
circulation in patients with coronary artery disease. Life Sci.
207:145–151. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Muñoz-Pacheco P, Ortega-Hernández A, Miana
M, Cachofeiro V, Fernández-Cruz A and Gómez-Garre D: Ezetimibe
inhibits PMA-induced monocyte/macrophage differentiation by
altering microRNA expression: A novel anti-atherosclerotic
mechanism. Pharmacol Res. 66:536–543. 2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cai X, Nie J, Chen L and Yu F:
Circ_0000267 promotes gastric cancer progression via sponging
MiR-503-5p and regulating HMGA2 expression. Mol Genet Genomic Med.
8(e1093)2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wu D, Cao G, Huang Z, Jin K, Hu H, Yu J
and Zeng Y: Decreased miR-503 expression in gastric cancer is
inversely correlated with serum carcinoembryonic antigen and acts
as a potential prognostic and diagnostic biomarker. Onco Targets
Ther. 10:129–135. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Yuan C, Lai CW, Chan LW, Chow M, Law HK
and Ying M: Cumulative effects of hypertension, dyslipidemia, and
chronic kidney disease on carotid atherosclerosis in Chinese
patients with type 2 diabetes mellitus. J Diabetes Res.
2014(179686)2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Assmann TS, Recamonde-Mendoza M, Costa AR,
Puñales M, Tschiedel B, Canani LH, Bauer AC and Crispim D:
Circulating miRNAs in diabetic kidney disease: Case-control study
and in silico analyses. Acta Diabetol. 56:55–65. 2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Chen YC, Bui AV, Diesch J, Manasseh R,
Hausding C, Rivera J, Haviv I, Agrotis A, Htun NM, Jowett J, et al:
A novel mouse model of atherosclerotic plaque instability for drug
testing and mechanistic/therapeutic discoveries using gene and
microRNA expression profiling. Circ Res. 113:252–265.
2013.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Borissoff JI, Heeneman S, Kilinç E, Kassák
P, Van Oerle R, Winckers K, Govers-Riemslag JW, Hamulyák K, Hackeng
TM, Daemen MJ, et al: Early atherosclerosis exhibits an enhanced
procoagulant state. Circulation. 122:821–830. 2010.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Han Z, Hu H, Yin M, Li X, Li J, Liu L and
Liu B: miR-145 is critical for modulation of vascular smooth muscle
cell proliferation in human carotid artery stenosis. J Biol Regul
Homeost Agents. 32:506–516. 2018.PubMed/NCBI
|
|
36
|
Janczak D, Ziolkowski P, Szydelko T,
Dorobisz T, Janczak D, Dorobisz K and Chabowski M: The presence of
some cytokines and Chlamydia pneumoniae in the atherosclerotic
carotid plaque in patients with carotid artery stenosis. Postepy
Hig Med Dosw (Online). 69:227–232. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Chen J, Cui L, Yuan J, Zhang Y and Sang H:
Circular RNA WDR77 target FGF-2 to regulate vascular smooth muscle
cells proliferation and migration by sponging miR-124. Biochem
Biophys Res Commun. 494:126–132. 2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Zhou B, Ma R, Si W, Li S, Xu Y, Tu X and
Wang Q: MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor
angiogenesis and growth. Cancer Lett. 333:159–169. 2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kim J, Kang Y, Kojima Y, Lighthouse JK, Hu
X, Aldred MA, McLean DL, Park H, Comhair SA, Greif DM, et al: An
endothelial apelin-FGF link mediated by miR-424 and miR-503 is
disrupted in pulmonary arterial hypertension. Nat Med. 19:74–82.
2013.PubMed/NCBI View
Article : Google Scholar
|
